Healthtech funding in H2 2018
European Healthtech startup funding raised during H2 2018.
In H2 2018, 123 European Healthtech companies closed 125 funding rounds and raised €1.3B in equity funding (excluding debt and grants), down 22.8% versus H2 2017. France led by capital raised, and Bpifrance was the most active investor. Data as of 20 Nov 2026.
Equity funding
€1.3B
-22.8% vs H2 2017 · excl. debt & grants
Funding rounds
125
-19.4% vs H2 2017
Companies
123
Top country
France
Rank among sectors
#3
10.1% of sector funding
Top-10 round share
51.5%
of disclosed capital
Rounds ≥ €100M
2
Funding by month
€ raised vs rounds, by monthHealthtech — funding by month, H2 2018 — interactive chart.
Data table
| Funding | Rounds | |
|---|---|---|
| Jul | €24M | 7 |
| Aug | €81M | 20 |
| Sep | €227M | 19 |
| Oct | €205M | 29 |
| Nov | €559M | 23 |
| Dec | €250M | 27 |
Top countries
by € raisedHealthtech — top countries by capital, H2 2018 — interactive chart.
Data table
| Healthtech — top countries by capital, H2 2018 | |
|---|---|
| France | €332M |
| Switzerland | €248M |
| UK | €221M |
| Israel | €141M |
| Ireland | €99M |
| Denmark | €97M |
| Germany | €67M |
| Belgium | €54M |
Stage mix
by € raisedHealthtech — stage mix, H2 2018 — interactive chart.
Data table
| Healthtech — stage mix, H2 2018 | |
|---|---|
| Other | €593M |
| Series B | €351M |
| Series C | €210M |
| Series A | €160M |
| Seed | €29M |
| Grant | €1.9M |
| Early VC | €1.2M |
| Pre-Seed | €679k |
Exits & M&A
5 Acquisition5 exits.
Top deals
largest disclosed rounds in H2 2018| Company | Stage | Date | Amount |
|---|---|---|---|
| Roivant Sciences | Other | Nov 2018 | €178M |
| Acticor biotech | Series B | Nov 2018 | €153M |
| Galecto Biotech | Series C | Oct 2018 | €79M |
| MeMed | Series C | Sep 2018 | €60M |
| Docly | Other | Sep 2018 | €54M |
| Inflazome | Series B | Nov 2018 | €40M |
| Camel-IDS | Series A | Nov 2018 | €37M |
| Min Doktor | Other | Sep 2018 | €32M |
| Owlstone Medical | Other | Oct 2018 | €30M |
| Nuritas | Series B | Dec 2018 | €30M |
| CARMAT | Other | Dec 2018 | €30M |
| AMAL | Series B | Nov 2018 | €29M |
| Fluidic Analytics | Other | Nov 2018 | €27M |
| Whiteswell | Series B | Dec 2018 | €26M |
| Renalytix AI | Series A | Nov 2018 | €26M |
Top investors
most active in H2 2018, by deal count- Bpifrance4 deals
- High-Tech Gründerfonds (HTGF)3 deals
- ADV2 deals
- Almi Invest2 deals
- European Investment Bank (EIB)2 deals
- Forbion2 deals
- Horizons Ventures2 deals
- Kima Ventures2 deals
- OurCrowd2 deals
- Panakès Partners2 deals